Leuprolide - NDC Database (Page 2)
62935-163 Mar 06, 2023
Fensolvi 45 mg/.375ml Subcutaneous Injection, Suspension, Extended Release by Tolmar Inc.
Fensolvi 45 mg/.375ml Subcutaneous Injection, Suspension, Extended Release by Tolmar Inc.
70121-2537 Nov 07, 2022
Leuprolide AcetateLeuprolide Acetate Subcutaneous Kit by Amneal Pharmaceuticals LLC
Leuprolide AcetateLeuprolide Acetate Subcutaneous Kit by Amneal Pharmaceuticals LLC
71288-569 May 15, 2024
Leuprolide AcetateLeuprolide Acetate Subcutaneous Kit by Meitheal Pharmaceuticals Inc
Leuprolide AcetateLeuprolide Acetate Subcutaneous Kit by Meitheal Pharmaceuticals Inc
85043-025 Aug 04, 2025
Vabrinty 22.5 mg/.375ml Subcutaneous Injection, Suspension, Extended Release by Uronova Pharmaceuticals, Inc.
Vabrinty 22.5 mg/.375ml Subcutaneous Injection, Suspension, Extended Release by Uronova Pharmaceuticals, Inc.
85043-030 Aug 04, 2025
Vabrinty 22.5 mg/.375ml Subcutaneous Injection, Suspension, Extended Release by Uronova Pharmaceuticals, Inc.
Vabrinty 22.5 mg/.375ml Subcutaneous Injection, Suspension, Extended Release by Uronova Pharmaceuticals, Inc.
85043-045 Aug 04, 2025
Vabrinty 45 mg/.375ml Subcutaneous Injection, Suspension, Extended Release by Uronova Pharmaceuticals, Inc.
Vabrinty 45 mg/.375ml Subcutaneous Injection, Suspension, Extended Release by Uronova Pharmaceuticals, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.